![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risperidone to olanzapine switch worth it in schizophrenia
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine and risperidone on a par in schizophrenia
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine and risperidone on a par in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Switch from Risperidone to Perospirone in Patients with Chronic Schizophrenia
By Fujita K.
Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. :